Author index of abstracts

Download Author index of abstracts

Post on 02-Jul-2016

215 views

Category:

Documents

2 download

Embed Size (px)

TRANSCRIPT

<ul><li><p>ELSEVIER Immunopharmacology 49 (2000) 199-2 17 www.elsevier.com/locate/immpharm </p><p>Author Index of Abstracts </p><p>Abe, M., Shim&amp; N., Shibata, K., Sakata, N., Katsuragi, T., Akatsu, H. and Okada, H., Evaluating a role of complement activation in allergic lung damage induced by repeated inhala- tion of antigen (49) 26 </p><p>Abrahams, J.P., see Bos, I.G.A.C. (49) 41 Abrahamsen, M.S., see Dalmasso, A.P. (49) 67 Accardo, P., see Amodeo, G. (49) 24 Acker, G., see Kraiczy, P. (49) 75 Affleck, L.J., see Dodd, I. (491 63 Agostoni, A., see Bergamaschini, L. (49) 23 Agostoni, A., see Carugati, A. (49) 27 Agostoni, A., see Gioffrt, D. (49) 27 Agostoni, A., see Gobbo, G. (49) 61 Agostoni, A., see Cugno, M. (49) 62 Aheam, J.M., see Navratil, J.S. (49) 36 Ahearn, J.M., see Liang, H. (49) 58 Akatsu, H., see Abe, M. (49) 26 Akatsu, H., see Dean, Y.D. (49) 41 Alarcon, G., see Moulds, J.M. (49) 29 Aleshin, Yu.N., see Galebskaya, L.V. (49) 23 Alexander, J.J. and Quigg, R.J., Factor H on rodent platelets </p><p>functions as the immune adherence receptor (49) 49 Alkimin, M.G.A., see Liberatore Jr., R.D.R. (49) 27 Al Mohanna, F., see Kotwal, G.J. (49) 76 Alves, C.M.O.S., see Marzocchi-Machado, CM. (49) 90 Alving, C.R., see Szebeni, J. (49) 71 Amadei, B., see Caprioli, J. (49) 13 Ambrus, G., see Zavodszky, P. (49) 89 Ames, R.S., Lee, D., Foley, J.J., Tometta, M.A., Bautsch, W., </p><p>Settmacher, B., Klos, A., Sulpizio, A.C., Hieble, J.P., McCaf- ferty, G. and Sarau, H.M., Pharmacology of SB 290157, a selective small molecule antagonist of the C3a receptor (49) 53 </p><p>Amodeo, G., D Amelio, L., Palombo, G., DArpa, N., Accardo, P., Mesellis, M. and Brai, M., Plasma soluble CR1 as a prognostic factor in severe burns (49) 24 </p><p>Amodeo, G., Neri, S., Cicardi, M., Riela, A. and Brai, M., ClINH abuse: whim or necessity (491 61 </p><p>Anderson, R., see Parent, J.B. (49) 68 Andersson, J., Nilsson Ekdahl, K. and Nilsson, B., Monitoring of </p><p>complement activation on a biomaterial surface (49) 96 Andrl, J., Halter, R., Heske, C., Paul, D. and Vogel, C.-W., </p><p>Transgenic mice expressing cobra venom factor (49) 94 And&amp; J., see Bammert, H. (49) 12 Andrl, J., see Wehrhahn, D. (49) 94 </p><p>Andrews, E., Lassiter, H., Feldhoff, R. and Feldhoff, P., Cytokine regulation of complement secretion by HepG2 cells (49) 19 </p><p>Andrews, M., see Botto, M. (49) 36 Anker Peterslund, N., see Thiel, S. (49) 85 Antonov, I.V., see Myones, B.L. (49) 97 Arlaud, G., see Gaboriaud, C. (49) 33 Arlaud, G.J., see Tacnet, P. (49) 16 Arlaud, G.J., see Rossi, V. (49) 17 Arlaud, G.J., see Thielens, N. (49) 87 Amett, F.C., see Rupert, K.L. (49) 29 Arora, M., Arora, R., Das, N. and Srivastava, L.M., Expression of </p><p>complement regulatory proteins in idiopathic focal segmental glomerulosclerosis (49) 28 </p><p>Arora, R., see Arora, M. (49) 28 Atkinson, J., see Liszewski, M.K. (49) 54 Atkinson, J.P., see Gioffre, D. (49) 27 Atkinson, J.P., see Mallin, R. (49) 46 Atkinson, J.P., see Smith, B.O. (49) 46 Atkinson, J.P., see Krych-Godberg, M. (49) 62 Atkinson, J.P., see Brodbeck, W.G. (49) 65 Atkinson, J.P., see Kemper, C. (49) 66 Atkinson, J.P., see Moulds, J.M. (49) 73 Atkinson, J.P., see Kallstrom, H. (49) 75 Ayub, S., see Sivasankar, B. (49) 28 Ayub, S., Sharma, M., Sivasankar, B., Katyal, M. and Das, N., </p><p>Modulation of serum complement and macrophage activation by organophosphate insecticide malation (49) 48 </p><p>Azzolini, A.E.C.S., see Marzocchi-Machado, CM. (49) 90 </p><p>Badea, T., Niculescu, F., Soane, L., Shin, M.L. and Rus, H., Molecular cloning and expression of human RGC-32, a novel gene induced by complement and involved in cdc2 activation (49) 93 </p><p>Badea, T., see Niculescu, F. (49) 93 Bajtay, Zs., see Erdei, A. (49) 84 Baker, L., see Loveland, B.E. (49) 66 Bala Subramanian, V., see Liszewski, M.K. (49) 54 Baldwin, I., see Loveland, B.E. (49) 66 Bally, I., see Gaboriaud, C. (49) 33 Bally, I., see Rossi, V. (49) 17 Bamber, L., see Dodd, I. (49) 63 Bammert, H., Kunze, B., Fritzinger, D.C., Bredehorst, R., And@ </p><p>J. and Vogel, C.-W., Initial characterization of the cobra venom factor gene (49) 12 </p></li><li><p>200 Aufhor Index of Abstracts </p><p>Banki, Z., see Erdei, A. (49) 84 Bao, L., see Kang, H.J. (49) 49 Baranyi, L., see Szebeni, J. (49) 71 Barbashov, S.F., see Ghiran, I. (49) 86 Barbosa, S.F.C., see Liberatore Jr., R.D.R. (49) 27 Barel, M. and Frade, R., Characterization of the ~95 cellular </p><p>component phosphorylated on tyrosine after activation of the C3d/Epstein-Barr virus receptor (gpl40, CR2, CD211 on human B lymphocytes (49150 </p><p>Bare], M.. see Le Romancer, M. (491 50 Barenholz, Y., see Szebeni, I. (49) 71 Barilla-La Barca, M.L., see Gioffre, D. (49) 27 Barlow, P., see Liszewski, M.K. (491 54 Barlow, P., see Kotwal, G.J. (49) 76 Barlow, P.N., see Mallin, R. (491 46 Barlow, P.N., see Smith, B.O. (49) 46 Barlow, P.N., see Herbert, A.P. (49) 6.5 Barnum, S., see Campos-Torres, A. (49) 48 Barrington, R.A., Zafari, M., Fischer, M.B., Pozdnyakova, O.O., </p><p>Benjamin, C. and Carroll, M.C., Role of complement and Fey receptors in maintenance of B lymphocyte memory (49) 37 </p><p>Barrington, R.A., Zhang, M., Pozdnyakova, 0.0. and Carroll, M.C., Complement-ligand requirement for B lymphocyte sur- vival in germinal centers during a primary response (49) 37 </p><p>Barrington, R.A., see Pozdnyakova, 0.0. (49) 50 Barrington, R.A., see Zhang, M. (491 50 Basheer, S., see Pratt, J.R. (49) 23 Basta, M., In-vitro inhibition of histamine and thromboxane re- </p><p>lease from mast cells by high-dose intravenous immunoglobu- lin (IVIG) (49) 94 </p><p>Bautsch, W., see Dahlke, M. (49) 12 Bautsch, W., see Grove, M. (49) 25 Bautsch, W., see Hawlisch, H. (49) 44 Bautsch, W., see Ames, R.S. (491 53 Bautsch, W., see Settmacher, B. (49) 89 Bellinati-Pires, R., see Liberatore Jr., R.D.R. (49) 27 Bellomo, R., see Loveland, B.E. (491 66 Benjamin, C., see Barrington, R.A. (49) 37 Benson, B.A., see Dalmasso, A.P. (49) 67 Benzing, W.C., see Parent, J.B. (49) 68 Bergamaschini, L., Gobbo, G., Rossi, E., Ponti, A., Gatti, S., </p><p>Caccamo, L., Braidotti, P. and Agostoni, A., Cl-inhibitor potentiates the protective effect of graft preservation solution during cold storage (49) 23 </p><p>Bergamaschini, L., see Gobbo, G. (49) 61 Bergg?trd, K., Lindahl, G., Dahlback, B. and Blom, A., Bordetella </p><p>percussis binds to human C4BP (C4b-binding protein) at a site similar to that used by the natural ligand C4b (491 75 </p><p>Berggtid, K., see Blom, A.M. (491 74 Bergseth, G., see Mollnes, T.E. (49) 62 Bergseth, G., see Fure, H. (49) 70 Bettinaglio, P.. see Caprioli, J. (49) 13 Bialonski, A., see Meri, T. (491 57 Billington, S.J., see Tambourgi, D.V. (491 19 Birmingham, D., see Moulds. J.M. (491 73 Birmingham, D.J., Liang, G. and Shen, X.-P., CR1 polymor- </p><p>phisms associated with SLE (491 29 </p><p>Birmingham, D.J., Logar, C.M. and Chen, W., Characterization of the human CRl-like transcript (49) 11 </p><p>Bjorge, L., Matre, R. and Meri, S., Cell cycle analysis of CD59 expression in ovarian cancer cell lines (49) 21 </p><p>Blackmer, D., see Krych-Godberg, M. (49) 62 Blackmer, D.J., see Kallstrom, H. (49) 75 Blanchong, C.A., see Yung Yu, C. (49) 32 Blazquez, A.B., see Pastor, C. (491 96 Blazquez, A.B., see Vidarte, L. (49) 40 Blok, V.T., see Gelderman, K.A. (49) 21 Blom, A., see Ram, S. (49) 58 Blom, A., see BerggCd, K. (491 75 Blom, A.M., Villoutreix, B.O., Webb, J.H., Berggird, K., Foltyn- </p><p>Zadura, A., Lindahl, G. and Dahlback, B., A Cluster of positively charged amino acids at the interface between C4BP CCPl and CCP2 is crucial for binding of C4b and streptococ- cal proteins (49) 74 </p><p>Blom, A.M., see Webb, J.H. (49) 96 Blouin, J., see Fremeaux-Bacchi, V. (49) 14 Blouin, J., see Dragon-Durey, M.A. (49) 25 Boackle, S.A., Brown, J.M. and Holers, V.M.. Role of Comple- </p><p>ment Receptors Type 1 (CRl/CD35) and Type 2 (CR2/ CD211 in murine SLE (49) 29 </p><p>Bock, D., see Settmacher, B. (49) 89 Bohana-Kashtan, O., see Fishelson, Z. (49) 97 Booth, CL., see Jack, D.L. (49) 88 Bos, I.G.A.C., Hoedemaeker, P.J., Hack, C.E. and Abrahams, </p><p>J.P., A novel 3D model of Cl-Inhibitor based on the crystal structure of 4 intact serpins (49) 41 </p><p>Botto, M., Taylor, P.R., Carugati, A., Fadok, V., Cook, H.T., Andrews, M., Carroll, M.C., Savill, J., Henson, P. and Wal- port, M.J., A hierarchical role for classical pathway comple- ment proteins in the clearance of apoptotic cells in GL.o: a mechanism for protection against autoimmunity (49) 36 </p><p>Botto, M., see Mitchell, D.A. (49) 18 Botto, M., see Pickering, M.C. (49) 18 Botto, M., see Robson, M.G. (491 27 Botto, M., see Robson, M.G. (491 28 Botto, M., see Norsworthy, P.J. (49) 36 Botto, M., see Holt, D.S. (49) 67 Botto, M., see Petty, F. (491 79 Bovin, N.V., see Roos, A. (49) 18 Bowen, F.W., see Soulika, A.M. (491 62 Brade, V., see Kraiczy, P. (49) 57 Brade, V., see Kraiczy, P. (49) 75 Bradley, J., see Harrison, R. (491 63 Bradt, B.M., see Yu, J.X. (49) 7 Bradt, B.M., see Yu, J.X. (491 14 Brai, M., see Amodeo, G. (49) 24 Brai, M., see Amodeo, G. (49) 61 Braidotti, P., see Bergamaschini, L. (49) 23 Brandon, M.R., see Loveland, B.E. (49) 66 Bredehorst, R., see Bammert, H. (491 12 Bredehorst, R., see Wehrhahn, D. (49) 94 Brekke, O.L., see Mollnes, T.E. (49) 62 Brekke, O.L., see Fure, H. (49) 70 Brockman. M.A., see Verschoor. A. (49) 72 </p></li><li><p>Author Index of Abstracts 201 </p><p>Brodbeck, W.G., Mold, C., Atkinson, J.P. and Medof, M.E., Cicardi, M., see Amodeo, G. (49) 61 Cooperation between decay accelerating factor and membrane Ciganda, M., Willis, A.C., Dalton, J.P. and Diaz, A., Effects on cofactor protein in protecting cells from autologous comple- C3 of the secreted cathepsin L proteinases from the parasite ment attack (49) 65 Fasciola hepatica (49) 74 </p><p>Brown, J.M., see Boackle, S.A. (491 29 Brunden, K.R., see Gupta-Bansal, R. (49) 68 Brunden, K.R., see Parent, J.B. (49) 68 Butcher, G.A., see Margos, G. (49) 73 Bygrave, A.E., see Holt, D.S. (49) 67 Bygraves, A.E., see Norsworthy, P.J. (49) 36 </p><p>Circolo, A., see Sekine, H. (49) 28 Clemenza, L. and Isenman, D.E., Structure-guided identification </p><p>of C3d residues essential for binding to complement receptor 2 (49) 33 </p><p>Caccamo, L., see Bergamaschini, L. (49) 23 Calabresi, M., see Schwaeble, W.J. (491 15 Campbell, I., see Campos-Torres, A. (49) 48 Campos-Torres, A., Reiman, R., Martin, B., Campbell, I. and </p><p>Barnum, S., Characterization of transgenic mice overexpress- ing the complement anaphylatoxin CSa in the CNS (49) 48 </p><p>Capey, S., see Van den Berg, C.W. (49) 92 Caprioli, J., Bettinaglio, P., Zipfel, P.F., Vasile, B., Gamba, S., </p><p>Amadei, B., Orisio, S., Remuzzi, G. and Noris, M., Mutations of factor H (HF) in familial hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP) (49) 13 </p><p>Carpenter, P., see Fonseca, M.I. (49) 17 Carroll, M., see Gadjeva, M. (49) 12 Carroll, M.C., see Botto, M. (49) 36 Carroll, M.C., see Barrington, R.A. (49) 37 Carroll, M.C., see Paul, E. (49) 42 Carroll, M.C., see Pozdnyakova, 0.0. (49) 50 Carroll, M.C., see Zhang, M. (49) 50 Carroll, M.C., see Verschoor, A. (491 72 Carroll, M.C., see Pozdnyakova, 0.0. (49) 79 Carroll, M.C., see Xu, Y. (49) 80 Carugati, A., Zingale, L.C., Rivolta, E., Agostoni, A. and Cicardi, </p><p>M., Hereditary Cl inhibitor deficiency increases the risk for renal diseases (49) 27 </p><p>Collan, J., see Harjunpa&amp; A. (49) 20 Collard, CD., Montalto, M. and Stahl, G.L., Endothelial oxidative </p><p>stress increases cytokeratin 1 (Kl) expression and human mannose-binding lectin (MBL) deposition (49) 85 </p><p>Colman, R.W., see Cugno, M. (49) 62 Colten, H., see Sekine, H. (49) 28 Condino-Neto, A., see Leitao, M.F. (49) 14 Connolly, C.C., see Test, ST. (49) 44 Convery, M., see Gupta-Bansal, R. (491 68 Convery, M., see Parent, J.B. (49) 68 Cook, H.T., see Mitchell, D.A. (49) 18 Cook, H.T., see Robson, M.G. (491 27 Cook, H.T., see Robson, M.G. (49) 28 Cook, H.T., see Botto, M. (49) 36 Cooke, H.T., see Pickering, M.C. (49) 18 Cooper, N.R., see Yu, J.X. (491 7 Cooper, N.R., see Yu, J.X. (49) 14 Cozzi, E., see Harrison, R. (49) 63 Cseh, S., see Thielens, N. (491 87 Cseh, S., see Zavodszky, P. (49) 89 Cugno, M., Vecchi, M., Devani, M., Sainz, I., De Franchis, R., </p><p>Agostoni, A. and Colman, R.W., Increased Cl-inhibitor levels and lack of contact system activation in plasma from patients with Crohns disease (49) 62 </p><p>Cui. W., see Liszewski, M.K. (49) 54 Cullinane, M., see Ram, S. (49) 58 </p><p>Carugati, A., see Botto, M. (49) 36 Casarsa, C., Pausa, M., De Luigi, A., De Simoni, M.G. and </p><p>Tedesco, F., Leukocyte migration in the cerebrospinal fluid induced by the injection of the terminal complement complex in the lateral ventricle of rats (49) 17 </p><p>Chanan-Khan, A.A., see Szebeni, J. (49) 71 Chavez, G., see Harrison, R. (49) 63 Chen, W., see Birmingham, D.J. (49) 11 Chesne, S., see Villiers, C.L. (49) 48 Chevallier, S., see Tacnet, P. (49) 16 Cho, H., see Soane, L. (49) 16 Christensen, T., see Dahl, M.R. (49) 79 Christiansen, D., see Mollnes, T.E. (49) 62 Christiansen, D., see Loveland, B.E. (49) 66 Chronopoulou, E., Ember. J.A., Song, S., Dong, L.P., Ji, X.-D., </p><p>Wang, X.D., Zou, J.-C., Shi, L., Stall, A., Sanderson, S.D., Shih, C.C.-Y. and Morgan, E., C5a- and C3a-receptors de- tected with high affinity monoclonals of rabbit and mouse origin (49) 89 </p><p>Dabhia, N., see Lassiter, H. (49) 22 Daha, M.R., see Roos, A. (49) 18 Daha, M.R., see Roos, A. (49) 83 Daha, M.R., see Nauta, A.J. (49) 95 Dahl, M.R., Thiel, S., Willis, A.C., Vorup-Jensen, T., Christensen, </p><p>T., Petersen, S.V. and Jensenius, J.C., Mannan-binding lectin associated serine protease 3 (MASP-3) a new component of the lectin pathway of complement activation (49) 79 </p><p>Dahlback, B., see Blom, A.M. (49) 74 Dahlback, B., see Bergglrd, K. (49) 75 Dahlback, B., see Webb, J.H. (49) 96 Dahlback, B., see Ram, S. (49) 58 Dahlke, M., Hawlisch, H., Link, C., Bautsch, W., Klos, A. and </p><p>Kohl, J., Selection of a neoepitope specific anti gp C3AdesArg single chain Fv fragment from a combinatoral rabbit antibody library (49) 12 </p><p>Cicardi, M., see Carugati, A. (49) 27 Cicardi, M., see Gioffre, D. (49) 27 </p><p>Dalmasso, A.P., Benson, B.A. and Abrahamsen, M.S., Role of CD59 upregulation in endothelial cells protected from comple- ment in a model of xenotransplantation (49) 67 </p><p>Dalton, J.P., see Ciganda, M. (49) 74 DAmelio, L., see Amodeo, G. (49) 24 </p></li><li><p>202 Author Index of Abstracts </p><p>Danino, D., see Szebeni, J. (49) 71 Dankert, J.R., see Ocana-Morgner, C. (49) 72 DArpa, N., see Amodeo, Cl. (49) 24 Das, N., see Arora, M. (491 28 Das, N., see Sivasankar, B. (49) 28 Das, N., see Ayub, S. (49) 48 Dashiell, SM., see Hafer-Macko, C. (49) 16 Davies, A., see Smith, G.P. (49) 53 Davies, A., see Margos, G. (49) 73 Davies, A., see Femie-King, B.A. (49) 74 Davies, K.A., see Robson, M.G. (491 27 Davies, K.A., see Robson, M.G. (491 28 Davis III, A.E., see Zahedi, K. (491 41 Davis III, A.E., see Zahedi, R. (491 61 Dean, Y.D., McGreal, E.P., Akatsu, H., Morgan, B.P. and Gasque, </p><p>P., Molecular cloning and tissue expression of the phagocytic complement Clq receptor in rat (49) 41 </p><p>Dean, Y.D., see McGreal, E.P. (49) 7 De Andrade, R.M.G., see Van den Berg, C.W. (491 95 De Barace, C., see D...</p></li></ul>